Pancreatic Surgery with Vascular Reconstruction in Patients with Locally Advanced Pancreatic Neuroendocrine Tumors

被引:32
|
作者
Haugvik, Sven-Petter [1 ,2 ]
Labori, Knut Jorgen [1 ]
Waage, Anne [1 ]
Line, Pal-Dag [3 ]
Mathisen, Oystein [1 ]
Gladhaug, Ivar Prydz [1 ,2 ]
机构
[1] Oslo Univ Hosp, Rikshosp, Dept Hepatopancreatobiliary Surg, N-0372 Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Oslo Univ Hosp, Rikshosp, Dept Organ Transplantat, N-0372 Oslo, Norway
关键词
PNET; Neuroendocrine; Pancreatic surgery; Vascular reconstruction; Pancreas; SUPERIOR MESENTERIC VEIN; ISLET-CELL CARCINOMA; PORTAL-VEIN; ENDOCRINE TUMORS; CURATIVE RESECTION; GRADING SYSTEM; THROMBUS; PANCREATICODUODENECTOMY; ADENOCARCINOMA; EPIDEMIOLOGY;
D O I
10.1007/s11605-013-2221-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pancreatic neuroendocrine tumors (PNET) are rare neoplasms with better prognosis than most pancreatic malignancies. Surgery of locally advanced PNET remains controversial, and the role of vascular reconstruction in this patient group has yet to be defined. The aim of this study was to evaluate the feasibility and outcome of pancreatic resections with vascular reconstruction in patients with locally advanced PNET. Retrospective analysis of patients who underwent pancreatic surgery with vascular reconstruction for locally advanced PNET at a single institution. Furthermore, a review of the relevant literature on the topic was performed. Seven patients who had undergone vascular reconstruction for locally advanced PNET were identified. Four patients had liver metastases at time of surgery. Postoperative complications developed in four patients with no mortality. Median follow-up time of all patients was 21 (range, 3-58) months. Three patients had disease in remission after 58, 42 and 3 months, respectively. One patient died 35 months postoperatively due to progressive disease, whereas three patients had progression of disease after 21, 9, and 4 months postoperatively. Pancreatic surgery with vascular reconstruction in patients with locally advanced PNET is feasible with acceptable outcome.
引用
收藏
页码:1224 / 1232
页数:9
相关论文
共 50 条
  • [21] Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors
    Dralle, H
    Krohn, SL
    Karges, W
    Boehm, BO
    Brauckhoff, M
    Gimm, O
    WORLD JOURNAL OF SURGERY, 2004, 28 (12) : 1248 - 1260
  • [22] Surgery of Resectable Nonfunctioning Neuroendocrine Pancreatic Tumors
    Henning Dralle
    Sabine L. Krohn
    Wolfram Karges
    Bernhard O. Boehm
    Michael Brauckhoff
    Oliver Gimm
    World Journal of Surgery, 2004, 28 : 1248 - 1260
  • [23] Vascular Resections in Association With Pancreatic Resections for Locally Advanced Pancreatic Cancer
    Bacalbasa, Nicolae
    Balescu, Irina
    Barbu, Ion
    Stiru, Ovidiu
    Savu, Cornel
    Pop, Lucian
    Al Aloul, Adnan
    Ursut, Bogdan
    Brasoveanu, Vladislav
    Petrea, Sorin
    IN VIVO, 2022, 36 (02): : 1001 - 1006
  • [24] Streptozocin-based chemotherapy in patients with advanced pancreatic neuroendocrine tumors
    Pavel, Marianne E.
    Dilz, Lisa-Marie
    Denecke, Timm
    Steffen, Ingo
    Prasad, Vikas
    Pape, Ulrich-Frank
    Pascher, Andreas
    Heetfeld, Maximilian
    Wiedenmann, Bertram
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [25] Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors
    Ramage, John
    Naraev, Boris G.
    Halfdanarson, Thorvardur R.
    SEMINARS IN ONCOLOGY, 2018, 45 (04) : 236 - 248
  • [26] Pancreaticoduodenectomy Combined with Vascular Resection and Reconstruction for Patients with Locally Advanced Pancreatic Cancer: A Multicenter, Retrospective Analysis
    Gong, Yi
    Zhang, Leida
    He, Tieying
    Ding, Jun
    Zhang, Hongyu
    Chen, Geng
    Zhang, Dong
    Wu, Zheng
    Chen, Qilong
    Fan, Haining
    Wang, Qi
    Bie, Ping
    Wang, Huaizhi
    PLOS ONE, 2013, 8 (08):
  • [27] Race is an Independent Predictor for Surgery Offer in Patients With Small Bowel Neuroendocrine Tumors But Not Pancreatic Neuroendocrine Tumors
    Rodriguez, Jorge Zarate
    Raper, Lacey
    Sanford, Dominic
    Trikalinos, Nikolaos
    Hammill, Chet
    PANCREAS, 2022, 51 (03) : E53 - E53
  • [28] SunitinibIn Advanced, Well Differentiated Pancreatic Neuroendocrine Tumors
    Emma D. Deeks
    Eric Raymond
    BioDrugs, 2011, 25 : 307 - 316
  • [29] Emerging treatment modalities for advanced pancreatic neuroendocrine tumors
    Alessandro Sindoni
    Fausto Famà
    Maria Gioffre-Florio
    Sergio Baldari
    Hormones, 2016, 15 : 563 - 564
  • [30] The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors
    Krug, Sebastian
    Gress, Thomas M.
    Michl, Patrick
    Rinke, Anja
    DIGESTION, 2017, 96 (02) : 67 - 75